Semi-Annual Consolidated Statement Of Cash Flows

DAIKEN MEDICAL CO.,LTD - Filing #7541406

Concept 2023-04-01 to
2023-09-30
As at
2023-09-30
As at
2023-03-31
2022-04-01 to
2022-09-30
As at
2022-09-30
As at
2022-03-31
Semi-annual consolidated statement of cash flows
Statement of cash flows
Cash flows from operating activities
Subtotal
802,293,000 JPY
546,090,000 JPY
Interest and dividends received
0 JPY
0 JPY
Interest paid
-2,488,000 JPY
-1,934,000 JPY
Income taxes paid
-197,086,000 JPY
-195,526,000 JPY
Net cash provided by (used in) operating activities
602,718,000 JPY
348,629,000 JPY
Cash flows from investing activities
Purchase of property, plant and equipment
-110,958,000 JPY
-103,087,000 JPY
Net cash provided by (used in) investing activities
-110,942,000 JPY
-104,033,000 JPY
Cash flows from financing activities
Repayments of long-term borrowings
-229,986,000 JPY
-368,238,000 JPY
Purchase of treasury shares
JPY
0 JPY
Dividends paid
-315,557,000 JPY
-306,762,000 JPY
Net cash provided by (used in) financing activities
-350,481,000 JPY
-480,658,000 JPY
Net increase (decrease) in cash and cash equivalents
141,294,000 JPY
-236,061,000 JPY
Cash and cash equivalents
2,657,507,000 JPY
2,516,212,000 JPY
2,282,527,000 JPY
2,518,589,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.